SCHEMBL8312829

SCHEMBL8312829

Cc1ccc2ccc(SO)cc2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 6/20 0.64
▸ CYP2A6 P11509 5/20 0.64
▸ TDP1 Q9NUW8 2/20 0.50
▸ HSD17B10 Q99714 3/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ ALOX15 P16050 2/20 0.37
▸ LMNA P02545 3/20 0.36
▸ GAA P10253 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ NCK1 P16333 1/20 0.36
▸ BACE1 P56817 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ TRPA1 O75762 2/20 0.36
▸ TP53 P04637 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ CA12 O43570 3/20 0.35
▸ CA9 Q16790 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL425085 0.80 CYP1A2 (1.00) CYP1A2CYP2A6TDP1HSD17B10ALDH1A1
SCHEMBL29399131 0.80 CYP1A2 (1.00) CYP1A2CYP2A6TDP1HSD17B10ALDH1A1
SCHEMBL9005232 0.79 CYP2A6 (0.67) CYP1A2CYP2A6TDP1HSD17B10ALDH1A1
SCHEMBL13223083 0.78 CYP2A6 (0.52) CYP1A2CYP2A6TDP1HSD17B10ALDH1A1
Ammonia Solution, Strong SCHEMBL27919194 0.77 CYP2A6 (0.93) CYP1A2CYP2A6TDP1HSD17B10ALDH1A1
Hydrochloric Acid SCHEMBL27326113 0.75 CYP1A2 (0.88) CYP1A2CYP2A6TDP1HSD17B10ALDH1A1
SCHEMBL237392 0.75 — —
SCHEMBL20342334 0.74 CYP2A6 (0.71) CYP1A2CYP2A6TDP1HSD17B10ALDH1A1
SCHEMBL1818017 0.73 CYP1A2 (0.50) CYP1A2CYP2A6TDP1HSD17B10ALDH1A1
SCHEMBL21081668 0.73 CYP2A6 (0.68) CYP1A2CYP2A6TDP1HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004083177-A2 LINEAR CHAIN SUBSTITUTED MONOCYCLIC AND BICYCLIC DERIVATIVES AS FACTOR XA INHIBITORS BRYSTOL-MYERS SQUIBB COMPANY (US) 2004-09-30 — — WO disclosed
Send feedback